The Manufacturers Life Insurance Company Buys Shares of 24,520 National Health Investors, Inc. $NHI

The Manufacturers Life Insurance Company purchased a new position in shares of National Health Investors, Inc. (NYSE:NHI) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 24,520 shares of the real estate investment trust’s stock, valued at approximately $1,870,000.

Other institutional investors also recently made changes to their positions in the company. International Assets Investment Management LLC acquired a new stake in shares of National Health Investors in the 4th quarter worth approximately $27,000. EverSource Wealth Advisors LLC raised its holdings in National Health Investors by 244.1% during the second quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust’s stock worth $28,000 after purchasing an additional 288 shares in the last quarter. Garton & Associates Financial Advisors LLC acquired a new stake in National Health Investors in the fourth quarter worth approximately $33,000. Allworth Financial LP acquired a new stake in National Health Investors in the second quarter worth approximately $42,000. Finally, Advisory Services Network LLC acquired a new stake in National Health Investors in the third quarter worth approximately $65,000. 62.51% of the stock is owned by institutional investors and hedge funds.

National Health Investors Trading Up 0.3%

Shares of NYSE:NHI opened at $71.73 on Friday. The stock has a market capitalization of $3.52 billion, a price-to-earnings ratio of 20.73, a PEG ratio of 3.82 and a beta of 0.52. National Health Investors, Inc. has a 1-year low of $67.94 and a 1-year high of $91.38. The company has a debt-to-equity ratio of 0.81, a quick ratio of 6.78 and a current ratio of 6.78. The company has a 50 day moving average price of $75.51 and a 200 day moving average price of $78.25.

National Health Investors (NYSE:NHI) last posted its quarterly earnings results on Monday, August 10th. The real estate investment trust reported $1.19 earnings per share (EPS) for the quarter. The company had revenue of $121.32 million for the quarter. National Health Investors had a return on equity of 10.89% and a net margin of 38.56%.National Health Investors’s quarterly revenue was up 1.6% on a year-over-year basis. During the same period in the prior year, the company posted $1.22 EPS. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. On average, research analysts anticipate that National Health Investors, Inc. will post 4.76 EPS for the current fiscal year.

National Health Investors Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, November 6th. Investors of record on Wednesday, September 30th will be issued a $0.92 dividend. This represents a $3.68 dividend on an annualized basis and a dividend yield of 5.1%. The ex-dividend date is Wednesday, September 30th. National Health Investors’s payout ratio is presently 106.36%.

Insider Activity

In related news, Director Robert A. Mccabe, Jr. bought 890 shares of the firm’s stock in a transaction that occurred on Monday, June 15th. The shares were acquired at an average cost of $71.65 per share, for a total transaction of $63,768.50. Following the acquisition, the director directly owned 44,159 shares of the company’s stock, valued at $3,163,992.35. The trade was a 2.06% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link. 2.70% of the stock is owned by insiders.

Analyst Ratings Changes

Several equities analysts have recently issued reports on NHI shares. Weiss Ratings cut National Health Investors from a “buy (b)” rating to a “buy (b-)” rating in a research report on Friday, June 12th. Truist Financial cut their price objective on National Health Investors from $81.00 to $80.00 and set a “buy” rating for the company in a report on Wednesday. Wells Fargo & Company decreased their target price on National Health Investors from $79.00 to $78.00 and set an “equal weight” rating for the company in a research note on Tuesday. BMO Capital Markets lowered their target price on National Health Investors from $90.00 to $80.00 and set an “outperform” rating on the stock in a report on Monday, June 15th. Finally, Deutsche Bank Aktiengesellschaft dropped their price target on shares of National Health Investors from $85.00 to $80.00 and set a “hold” rating on the stock in a research report on Thursday, June 25th. Five investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $83.57.

National Health Investors Company Profile

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.